Finch Therapeutics Group Inc

NASDAQ:FNCH

2.24

-0.12 (-5.08%)

7:24:10 PM EDT: $2.17 -0.07 (-3.13%)

Finch Therapeutics Group Inc Stock, NASDAQ:FNCH

75 State Street, Suite 100, Boston, Massachusetts 02109

United States of America

Phone: +1.617.229.6499

Number of Employees: 1

http://www.finchtherapeutics.com

Description

Finch Therapeutics Group, Inc. engages in the development of microbiome drugs. Its platform includes Human-First Discovery that enables reverse translation from clinical data to engineer the composition of the microbiome based on disease-modifying mechanisms. The company was founded by Mark Smith, Andrew Noh, Tom Borody and Zain Kassam in 2014 and is headquartered in Boston, MA.